Showing results (371-380 of 505) with videos related to
Sort By:
Pageof 51
Acta Haematologica|January 1, 1982
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb FP Cech, U Testa, A Dubart, et al.Allergy|December 21, 2013
IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitizationC Uermösi, F Zabel, V Manolova, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccinationMona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.Allergy|August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic responseMartin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.The Journal of Experimental Medicine|May 19, 1997
Role of repetitive antigen patterns for induction of antibodies against antibodiesT Fehr, M F Bachmann, E Bucher, et al.The Journal of Experimental Medicine|March 3, 1997
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosisT Fehr, G Schoedon, B Odermatt, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particlesSusanne A Keller, Caroline E von Allmen, Heather J Hinton, et al.Immunity|July 1, 1996
Duration of TCR stimulation determines costimulatory requirement of T cellsT M Kündig, A Shahinian, K Kawai, et al.Thrombosis and Haemostasis|September 6, 2003
Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2Christine Piossek, Karl-Heinz Thierauch, Jens Schneider-Mergener, et al.European Journal of Immunology|June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicityPatrik Maurer, Gary T Jennings, Jörg Willers, et al.Pageof 51